Advanced topics in evidence-based urological oncology: Using results of a subgroup analysis

Urologic Oncology: Seminars and Original Investigations

Volumn 29, Issue 4, 2011, Pages 462-466

  Scales, Charles D ^a   Canfield, Steven E ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Radical prostatectomy; Subgroup analysis; Watchful waiting

Indexed keywords

COMPARATIVE STUDY; EVIDENCE BASED MEDICINE; MEDICAL LITERATURE; ONCOLOGY; PRIORITY JOURNAL; REVIEW; THEORY VALIDATION; TREATMENT OUTCOME; TREATMENT PLANNING; UROLOGY; VALIDATION PROCESS;

CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROSTATECTOMY; PROSTATIC NEOPLASMS; REFERRAL AND CONSULTATION; UROLOGIC NEOPLASMS;

EID: 79959912114     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.01.007     Document Type: Review

References (19)

1. Guyatt G., Rennie D., Meade M.O., et al. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice 2008, The McGraw-Hill Companies, Inc., New York. 2nd ed.
2. Pocock S.J., Hughes M.D., Lee R.J. Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med 1987, 317:426-432.
3. Fletcher J. Subgroup analyses: How to avoid being misled. BMJ 2007, 335:96-97.
4. Oxman A.D., Guyatt G.H. A consumer's guide to subgroup analyses. Ann Intern Med 1992, 116:78-84.
5. Schulz K.F., Grimes D.A. Multiplicity in randomized trials II: Subgroup and interim analyses. Lancet 2005, 365:1657-1661.
6. Yusuf S., Wittes J., Probstfield J., et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991, 266:93-98.
7. Scales C.D., Norris R.D., Peterson B.L., et al. Clinical research and statistical methods in the urology literature. J Urol 2005, 174:1374-1379.
8. Krupski T.L., Dahm P., Fesperman S.F., et al. User's Guide to the urologic literature: How to perform a literature search. J Urol 2008, 1264-1270.
9. Krupski T.L., Schardt C.M., Fesperman S.F., et al. Evidence-based urology in practice: How to use PubMed effectively. BJU Int 2009, 103:1156-1159.
10. Scales C.D., Preminger G.M., Keitz S.A., et al. Evidence based clinical practice: A primer for urologists. J Urol 2007, 178:775-782.
11. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy vs. watchful waiting in early prostate cancer. N Engl J Med 2005, 352:1977-1984.
12. Bajammal S., Dahm P., Scarpero H.M., et al. How to use an article about therapy. J Urol 2008, 180:1904-1911.
13. Sun X., Briel M., Busse J.W., et al. Subgroup Analysis of Trials is Rarely Easy (SATIRE): A study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials. Trials 2009, 10:101.
14. Wang S.S., Ou Y.C., Cheng C.L., et al. Evidence-based urology in practice: When to believe a subgroup analysis?. BJU Int 2010, 105:162-164.
15. Wang R., Lagakos S.W., Ware J.H., et al. Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med 2007, 357:2189-2194.
16. Schneider B. Analysis of clinical trial outcomes: Alternative approaches to subgroup analysis. Control Clin Trials 1989, 10:176S-186S.
17. Hatala R., Keitz S., Wyer P., et al. Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. CMAJ 2005, 172:661-665.
18. Wilt T.J., MacDonald R., Rutks I., et al. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008, 148:435-448.
19. Iversen P., Madsen P.O., Corle D.K. Radical prostatectomy vs. expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study. Scand J Urol Nephrol Suppl 1995, 172:65-72.